Skip to main content
. 2017 Sep 12;7:11301. doi: 10.1038/s41598-017-11310-0

Figure 5.

Figure 5

Usage of TCR-Vβ in normal TFH cells (A), dominant AITL clones (B), and dominant PTCL-NOS clones (C).